Efficacy of intravesical bacillus calmette-guérin therapy against tumor immune escape in an orthotopic model of bladder cancer

Peng Huang, Chao Ma, Peng Xu, Kai Guo, Abai Xu, Chunxiao Liu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The aim of this study was to evaluate the antitumor immune response of the Bacillus Calmette-Guérin (BCG) in an orthotopic bladder cancer model. The murine bladder cancer cell line MBT-2 was transurethrally implanted in the bladder of syngeneic female C3H/He mice. The animals were randomly divided into three treatment groups: Phosphate-buffered saline (PBS), low-dose BCG and high-dose BCG. The analyses of luciferin-stained tumor images 28 days after each treatment showed significant tumor growth inhibition in the high-dose group in comparison with that in the low-doseor PBS-treated groups. In addition, the percentage of myeloid-derived suppressor cells in the high-dose group was significantly suppressed in comparison with that in the PBS and low-dose agent treatment groups. These findings are notable in terms of the clinical evaluations of this therapy for patients with bladder cancer. The outcomes of this study also provide important implications regarding antitumor immune responses in human cancer.

Original languageEnglish
Pages (from-to)162-166
Number of pages5
JournalExperimental and Therapeutic Medicine
Volume9
Issue number1
DOIs
Publication statusPublished - Jan 1 2015
Externally publishedYes

Fingerprint

Tumor Escape
Urinary Bladder Neoplasms
Bacillus
Phosphates
Neoplasms
Inbred C3H Mouse
Therapeutics
Urinary Bladder
Outcome Assessment (Health Care)
Cell Line
Growth

Keywords

  • Bacillus Calmette-Guérin
  • Bladder cancer
  • Immune-escape
  • Myeloid-derived suppressor cells

ASJC Scopus subject areas

  • Medicine(all)
  • Cancer Research
  • Immunology and Microbiology (miscellaneous)

Cite this

Efficacy of intravesical bacillus calmette-guérin therapy against tumor immune escape in an orthotopic model of bladder cancer. / Huang, Peng; Ma, Chao; Xu, Peng; Guo, Kai; Xu, Abai; Liu, Chunxiao.

In: Experimental and Therapeutic Medicine, Vol. 9, No. 1, 01.01.2015, p. 162-166.

Research output: Contribution to journalArticle

@article{e88049ff70e9463bbeb583b851af22b2,
title = "Efficacy of intravesical bacillus calmette-gu{\'e}rin therapy against tumor immune escape in an orthotopic model of bladder cancer",
abstract = "The aim of this study was to evaluate the antitumor immune response of the Bacillus Calmette-Gu{\'e}rin (BCG) in an orthotopic bladder cancer model. The murine bladder cancer cell line MBT-2 was transurethrally implanted in the bladder of syngeneic female C3H/He mice. The animals were randomly divided into three treatment groups: Phosphate-buffered saline (PBS), low-dose BCG and high-dose BCG. The analyses of luciferin-stained tumor images 28 days after each treatment showed significant tumor growth inhibition in the high-dose group in comparison with that in the low-doseor PBS-treated groups. In addition, the percentage of myeloid-derived suppressor cells in the high-dose group was significantly suppressed in comparison with that in the PBS and low-dose agent treatment groups. These findings are notable in terms of the clinical evaluations of this therapy for patients with bladder cancer. The outcomes of this study also provide important implications regarding antitumor immune responses in human cancer.",
keywords = "Bacillus Calmette-Gu{\'e}rin, Bladder cancer, Immune-escape, Myeloid-derived suppressor cells",
author = "Peng Huang and Chao Ma and Peng Xu and Kai Guo and Abai Xu and Chunxiao Liu",
year = "2015",
month = "1",
day = "1",
doi = "10.3892/etm.2014.2060",
language = "English",
volume = "9",
pages = "162--166",
journal = "Experimental and Therapeutic Medicine",
issn = "1792-0981",
publisher = "Spandidos Publications",
number = "1",

}

TY - JOUR

T1 - Efficacy of intravesical bacillus calmette-guérin therapy against tumor immune escape in an orthotopic model of bladder cancer

AU - Huang, Peng

AU - Ma, Chao

AU - Xu, Peng

AU - Guo, Kai

AU - Xu, Abai

AU - Liu, Chunxiao

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The aim of this study was to evaluate the antitumor immune response of the Bacillus Calmette-Guérin (BCG) in an orthotopic bladder cancer model. The murine bladder cancer cell line MBT-2 was transurethrally implanted in the bladder of syngeneic female C3H/He mice. The animals were randomly divided into three treatment groups: Phosphate-buffered saline (PBS), low-dose BCG and high-dose BCG. The analyses of luciferin-stained tumor images 28 days after each treatment showed significant tumor growth inhibition in the high-dose group in comparison with that in the low-doseor PBS-treated groups. In addition, the percentage of myeloid-derived suppressor cells in the high-dose group was significantly suppressed in comparison with that in the PBS and low-dose agent treatment groups. These findings are notable in terms of the clinical evaluations of this therapy for patients with bladder cancer. The outcomes of this study also provide important implications regarding antitumor immune responses in human cancer.

AB - The aim of this study was to evaluate the antitumor immune response of the Bacillus Calmette-Guérin (BCG) in an orthotopic bladder cancer model. The murine bladder cancer cell line MBT-2 was transurethrally implanted in the bladder of syngeneic female C3H/He mice. The animals were randomly divided into three treatment groups: Phosphate-buffered saline (PBS), low-dose BCG and high-dose BCG. The analyses of luciferin-stained tumor images 28 days after each treatment showed significant tumor growth inhibition in the high-dose group in comparison with that in the low-doseor PBS-treated groups. In addition, the percentage of myeloid-derived suppressor cells in the high-dose group was significantly suppressed in comparison with that in the PBS and low-dose agent treatment groups. These findings are notable in terms of the clinical evaluations of this therapy for patients with bladder cancer. The outcomes of this study also provide important implications regarding antitumor immune responses in human cancer.

KW - Bacillus Calmette-Guérin

KW - Bladder cancer

KW - Immune-escape

KW - Myeloid-derived suppressor cells

UR - http://www.scopus.com/inward/record.url?scp=84919448244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919448244&partnerID=8YFLogxK

U2 - 10.3892/etm.2014.2060

DO - 10.3892/etm.2014.2060

M3 - Article

VL - 9

SP - 162

EP - 166

JO - Experimental and Therapeutic Medicine

JF - Experimental and Therapeutic Medicine

SN - 1792-0981

IS - 1

ER -